MedPath

Fermented Millet Porridge, Gut Microbiota and Inflammation Status in Women

Not Applicable
Recruiting
Conditions
Microbiome, Human
Inflammation
Interventions
Other: Fermented porridge
Registration Number
NCT05299970
Lead Sponsor
Institut de Recherche en Sciences de la Sante, Burkina Faso
Brief Summary

Maternal undernutrition concerns 10-19% of women of reproductive age globally, the vast majority of which live in sub Saharan Africa and south Asia. Recommendations for nutritional interventions to tackle the problem range from per-pregnancy supplementation to upstream interventions targeting women of reproductive age before conception. To render the latter interventions cost-effective and sustainable, experts recommend to focus on food processing that leads to an enhanced nutrient content. One such method, which has been known and practiced for centuries in diverse societies, is fermentation. Traditionally fermented foods are diverse, widespread and highly appreciated in Burkina Faso. The present study aims to investigate the effect of fermented millet porridge on gut microbiota diversity, stool short chain fatty acid concentration and inflammation markers level in women of reproductive age living in rural Burkina Faso.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria

Participant are

  • 18 to 49 years old
  • Resident in the study area and do not plan to move within 5 months following the start of the study
  • Are not on antibiotic treatment on inclusion and have not been in the previous 3 weeks.
  • Do not suffer from any pathology that could interfere with their diet.
  • Have no known allergy to pearl millet or its derivatives
  • Agree to sign a consent to participate in the study-
Exclusion Criteria
  • Women under 18 or over 49
  • Women not consuming pearl millet porridge due to allergy or food preference
  • Women planning to move from the study area within 5 months of the start of the study
  • Women with serious illnesses that may interfere with their diet
  • Women on antibiotic treatment or at the time of inclusion or having been in the previous 3 weeks.
  • In addition, women who will benefit from antibiotic therapy during the study will be excluded from the analysis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
fermented porridgeFermented porridgethis study arm participant will consume fermented millet porridge, daily
Non-fermented porridgeFermented porridgethis study arm participants will consume non-fermented millet porridge, daily
Primary Outcome Measures
NameTimeMethod
Gut microbiota diversity0 to 13 weeks

gut microbiota alpha and beta diversity

Concentration of inflammation markers in blood and stool0 to 13 weeks

Concentration of IL1-beta, IL 8, IL 6, IL 33, TNF-alpha, lipocalin 2, myeloperoxidase, calprotectin

Secondary Outcome Measures
NameTimeMethod
Concentration of short chain fatty acid in stool0 to 13 weeks

Concentration of C2-C8 fatty acids in stool

relative abundance of bacterial and fugal micro-organisms in millet dough and porridge2 to 8 weeks

Count of microbial populations

concentration of macronutrients in millet dough and porridge2 to 8 weeks

Levels of carbohydrates, lipids, protein, dietary fiber and phytates

Concentration of Ferritin in plasma0- to 13 weeks

Ferritin levels in Plasma

Number of participant with anemia0 to 13 weeks

hemoglobin concentration in grams per deciliter

Trial Locations

Locations (1)

IRSS-DRO

🇧🇫

Bobo-Dioulasso, Houet, Région Des hauts-Bassins, Burkina Faso

© Copyright 2025. All Rights Reserved by MedPath